Jubilant Pharma

Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR of 3.9% | Exclusive Report by The Insight Partners

Jubilant Pharma arm to raise USD 400 million loan from Standard Chartered Bank to repay debt

JUBILANT PHARMA LIMITED

Dyslexia Treatment Market Expected to Achieve 7.10% CAGR, Reaching 62.26 Billion USD by 2032

National Sales Director

Jubilant Pharma Limited is a well-established member of the pharmaceutical and biopharmaceutical industries, recognized for its manufacturing of sterile injectable products. The National Sales Director will be responsible for driving the U.S. commercial strategy and leading a high-performing sales team to achieve revenue and growth targets while collaborating with various departments to ensure strategic alignment and customer engagement.

Sign up with Google

Sign in with Google